The exact frequency of NAD+ injections varies person to person
No, GLP-1 receptor agonists are not FDA-approved for joint pain treatment
This counterintuitive finding, where a lower dose shows higher risk than a higher dose, suggests that the relationship between tirzepatide and gallbladder problems may not be purely dose-dependent
In an animal study, BPC 157 was found to heal spinal cord injuries, reverse the effects on the brain of both alcohol overdose and long-term usage, reverse the brain effects of methamphetamine and opioid use, largely heal the effects of stroke, and show tremendous progress in treating schizophrenia
Tambini advises
In the SURPASS clinical trials for type 2 diabetes, nausea occurred in 1222% of patients, diarrhea in 1216%, and vomiting in 59%, with incidence varying by dose